Inventor · disambiguated record
David A. Ralph
Also filed as: RALPH DAVID · RALPH DAVID A · RALPH DAVID ALLEN
14 granted patents·25 pending applications·638 citations·filing 1996–2025
91Inventor score
Files withNAVIDEA BIOPHARMACEUTICALS INC21UROCOR INC5INTERGENETICS INC2OKLAHOMA MED RES FOUND2RALPH DAVID2
Top patents by PatentIndex Score
39 records- 0193US5882864ABiomarkers and targets for diagnosis, prognosis and management of prostate diseaseUROCOR INC·Filed 1996·Granted Mar 16, 1999·322 cites·64 claims
- 0291US11833170B2Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blockingNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Granted Dec 5, 2023·2 cites·16 claims
- 0391US6218529B1Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancerUROCOR INC·Filed 1998·Granted Apr 17, 2001·186 cites·38 claims
- 0491US6190857B1Diagnosis of disease state using MRNA profiles in peripheral leukocytesUROCOR INC·Filed 1998·Granted Feb 20, 2001·118 cites·26 claims
- 0590US11007272B1Compounds and methods for diagnosis and treatment of viral infectionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2017·Granted May 18, 2021·6 cites·12 claims
- 0682US11590236B2Compositions and methods for altering macrophage phenotypeNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·1 cites·9 claims
- 0781US12404349B2Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymersNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Granted Sep 2, 2025·0 cites·19 claims
- 0879US2025382392A1Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymersNAVIDEA BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0977US12297222B2CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linkerNAVIDEA BIOPHARMACEUTICALS INC·Filed 2024·Granted May 13, 2025·0 cites·13 claims
- 1077US2025325681A1Compositions and methods for altering macrophage phenotypeNAVIDEA BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1175US12178829B2Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blockingNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Granted Dec 31, 2024·0 cites·20 claims
- 1275US12006339B2CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linkerNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Granted Jun 11, 2024·0 cites·31 claims
- 1375US7332270B1Diagnosis of disease state using mRNA profiles in peripheral leukocytesUROCOR INC·Filed 2000·Granted Feb 19, 2008·3 cites·7 claims
- 1474US2023218770A1Compositions and methods for altering macrophage phenotypeNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1573US11859023B2Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereofNAVIDEA BIOPHARMACEUTICALS INC·Filed 2021·Granted Jan 2, 2024·0 cites·19 claims
- 1670US12005122B2Compounds and methods for diagnosis and treatment of viral infectionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2021·Granted Jun 11, 2024·0 cites·20 claims
- 1769US2009263808A1Genetic Analysis For Stratification of Cancer RiskRALPH DAVID·Filed 2009·Application pending·0 cites
- 1867US2023210998A1Methods for the conjugation of anthracyclines to carbohydrate polymeric carriersNAVIDEA BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1962US2023302041A1Competitive Self-Blocking with Unlabeled Manocept Imaging AgentsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2061US2024024491A1Mannosylated amine dextran drug delivery vehicles with degradable disulfide/carbonate linkers targeting payloads to cd206 expressing cellsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2161US2005021236A1Statistically identifying an increased risk for diseaseOKLAHOMA MED RES FOUND·Filed 2004·Application pending·0 cites
- 2260US2023070258A1Compositions and methods for the treatment of rheumatoid arthritisNAVIDEA BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2360US2006240450A1Genetic analysis for stratification of cancer riskRALPH DAVID·Filed 2006·Application pending·0 cites
- 2459US2005136438A1Genetic analysis for stratification of cancer riskFiled 2004·Application pending·0 cites
- 2559US2011124003A1Cytological Methods for Detecting CancerINTEGRATED BIOSCIENCE SOLUTIONS LLC·Filed 2009·Application pending·0 cites
- 2658US2004002071A1Genetic analysis for stratification of cancer riskINTERGENETICS INC·Filed 2002·Application pending·0 cites
- 2756US2009029375A1Genetic models for stratification of cancer riskINTERGENETICS INC·Filed 2008·Application pending·0 cites
- 2853US10408836B2Methods of detecting influenza virusUNIV CINCINNATI·Filed 2016·Granted Sep 10, 2019·0 cites·4 claims
- 2953US2008009419A1Genetic models for stratification of cancer riskOKLAHOMA MED RES FOUND·Filed 2007·Application pending·0 cites
- 3053US2020237937A1Compositions and methods for assessing macrophage mediated pathologyNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3153US2020108069A1Treatment of Fibrotic ConditionsANGLIA RUSKIN UNIV HIGHER EDUCATION CORPORATION·Filed 2019·Application pending·0 cites
- 3253US2003050470A1Biomarkers and targets for diagnosis, prognosis and management of prostate disease, bladder and breast cancerUROCOR INC·Filed 2001·Application pending·0 cites
- 3353US2021145989A1Compositions and related methods for blocking off-target localization of mannosylated dextrans and other cd206 ligandsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3451US2021052639A1Compositions and related methods for the ablation of m2 macrophages and myeloid derived suppressor cellsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3551US2009215668A1Methods of making and uses of compositions that modulate intronic region-encoded protein functionHONEYCUTT RHONDA J·Filed 2008·Application pending·0 cites
- 3649US2004170998A1Methods of making and uses of compositions that modulate intronic region-encoded protein functionFiled 2002·Application pending·0 cites
- 3748US2019022259A1Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3846US2012213789A1New Molecular Target for Treatment of CancerAN GANG·Filed 2011·Application pending·0 cites
- 3944US2019021608A1CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in HumansNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Ralph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →